AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Aug 13, 2025 | Sale | $9.22 | 161,365 | 1,487,785 | 460,517 | Aug 15, 2025, 04:30 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Aug 14, 2025 | Sale | $9.30 | 119,206 | 1,108,616 | 341,311 | Aug 15, 2025, 04:30 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Aug 15, 2025 | Sale | $9.43 | 219,159 | 2,066,669 | 122,152 | Aug 15, 2025, 04:30 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 05, 2025 | Sale | $8.91 | 100,000 | 891,000 | 621,882 | Mar 07, 2025, 04:17 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 04, 2025 | Option/RSU Exercise | - | 43,981 | - | 744,379 | Mar 05, 2025, 07:53 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 03, 2025 | Tax Payment (Shares) | $8.76 | 133,410 | 1,168,672 | 700,398 | Mar 05, 2025, 07:53 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 03, 2025 | Option/RSU Exercise | - | 283,789 | - | 793,061 | Mar 05, 2025, 07:53 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 04, 2025 | Tax Payment (Shares) | $8.84 | 22,497 | 198,873 | 721,882 | Mar 05, 2025, 07:53 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 01, 2025 | Tax Payment (Shares) | $8.67 | 13,494 | 116,993 | 550,019 | Mar 04, 2025, 06:59 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 01, 2025 | Option/RSU Exercise | - | 36,197 | - | 563,513 | Mar 04, 2025, 06:59 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 12, 2024 | Option/RSU Exercise | - | 87,720 | - | 558,106 | Mar 14, 2024, 04:17 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 12, 2024 | Tax Payment (Shares) | $5.31 | 30,790 | 163,495 | 527,316 | Mar 14, 2024, 04:17 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 12, 2023 | Option/RSU Exercise | - | 87,719 | - | 380,840 | Mar 14, 2023, 04:30 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 03, 2023 | Option/RSU Exercise | - | 45,289 | - | 293,121 | Mar 07, 2023, 06:00 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 01, 2023 | Option/RSU Exercise | - | 36,197 | - | 247,832 | Mar 03, 2023, 04:30 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 12, 2022 | Option/RSU Exercise | - | 87,719 | - | 211,635 | Mar 15, 2022, 05:30 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 01, 2022 | Option/RSU Exercise | - | 36,197 | - | 123,916 | Mar 03, 2022, 09:19 PM |
AMRX | | Amneal Pharmaceuticals, Inc. | Tasos Konidaris | Executive Vice President & CFO | Mar 12, 2021 | Option/RSU Exercise | - | 87,719 | - | 87,719 | Mar 15, 2021, 04:06 PM |